Dacomitinib/Dacomitinib price per box and market selling price

Dacomitinib/Dacomitinib (Dacomitinib) is a targeted therapy drug, mainly used to treat non-small cell lung cancer (NSCLC), especially advanced patients with positive EGFR gene mutations. As a tyrosine kinase inhibitor, dacomitinib can inhibit the growth and spread of tumor cells by blocking the EGFR pathway. The price of dacomitinib varies in different countries and regions and is affected by multiple factors such as market demand, production costs, and exchange rate fluctuations.

In China, the original drug of dacomitinib has been launched and has entered the scope of Class B medical insurance reimbursement. The common specifications are15mg*30 tablets per box, and the market price is about more than 1,000 yuan. With the coverage of medical insurance reimbursement, the burden on patients has been reduced, but for some patients, the financial burden of drugs is still an issue that requires concern.

In overseas markets, the price of dacomitinib is relatively expensive, especially in the European market. Taking the specification of 45mg*30 tablets as an example, the price of dacomitinib may be around more than 20,000 yuan, and the specific amount will fluctuate according to exchange rate changes. This price reflects the pricing strategy of the original drug in the high-end market, which is relatively high considering its therapeutic effect and market demand.

In addition to the original drug, dacomitinib also has generic versions in overseas markets, especially in Asian markets where prices are lower. For example, the generic version of dacomitinib produced by Lucius Pharmaceuticals and Element Pharmaceuticals from Laos has a specification of 45mg*30 tablets per box and sells for about RMB 800. Although these generic drugs are cheaper, the ingredients are the same as the original drugs, so patients can get similar therapeutic effects. The introduction of generic drugs has provided more affordable treatment options for some patients with limited economic conditions, especially in developing countries and regions.

Reference materials:https://www.pfizer.com/products/product-detail/vizimpro